News Gedeon Richter LUXEMBOURG S.E.

Stocks

CHWGR

US3684672054

Pharmaceuticals

End-of-day quote LUXEMBOURG S.E. 26/10/2026			5-day change	1st Jan Change
40.40 ^USD	+3.06%		+3.59%	+33.77%

14/10	Gedeon Richter Plc. Receives Fda Submission Acceptance of New Drug Application for Fylrevy® in the U.S	CI
18/09	EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug	MT

All News

Mentions Relevance

14/10	Gedeon Richter : Richter receives FDA Submission Acceptance of New Drug Application for FYLREVY in the U.S.	PU
14/10	Gedeon Richter Plc. Receives Fda Submission Acceptance of New Drug Application for Fylrevy® in the U.S	CI
11/08	Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026
07/08	Gedeon Richter PLC Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07/08	Gedeon Richter : Richter publishes Q2/H1 2026 results	PU
06/08	Gedeon Richter : Richter and Adalvo Expand Global Co-Development Partnership in Tirzepatide Across Diabetes and Obesity Care	PU
06/08	Gedeon Richter plc and Adalvo Expand Global Co-Development Partnership in Tirzepatide Across Diabetes and Obesity Care	CI
29/06	Gedeon Richter plc announces Resignation of Péter Cserháti as Member of the Board of Directors, with Effect from 1 July 2026	CI
10/06	Gedeon Richter : Richter and Hetero Announce Global Cooperation for the Development and Commercialization of Semaglutide Injection (Generic of Ozempic®)	PU
10/06	Gedeon Richter Plc. and Hetero Labs Ltd. Announce Global Collaboration Agreement for Joint Development, Registration, and Commercialization of Semaglutide Injection	CI
29/05	Gedeon Richter PLC Approves Dividend for the Financial Year 2025	CI
27/05	Hungary's Richter and Acrux agree to license transdermal estradiol spray for Australia	RE
27/05	Gedeon Richter : Richter and Acrux agree to license Lenzetto® for Australia	PU
16/05	Gedeon Richter PLC, Q1 2026 Earnings Call, May 12, 2026
14/05	Gedeon Richter : Transactions with Treasury Shares	PU
12/05	Gedeon Richter PLC Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
12/05	Gedeon Richter : Extraordinary Information	PU
12/05	Hungary's Richter says 2026 guidance fully reiterated high-single-digit growth in revenues and clean EBIT (at constant exchange rates)	RE
12/05	Gedeon Richter : Interim management statement	PU
12/05	Gedeon Richter : RichterIRpresentation May 2026	PU
12/05	Gedeon Richter : PresentationQ12026	PU
12/05	Gedeon Richter : Richter publishes Q1 2026 results	PU
12/05	Gedeon Richter : Earnings presentation Q1 2026 (PresentationQ12026)	PU
12/05	Gedeon Richter : Investor presentation Q1 2026 (RichterIRpresentation May 2026)	PU
12/05	Gedeon Richter Seeks Acquisitions	CI